• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤连蛋白和血管性血友病因子对人固定洗涤血小板与胶原固定微珠黏附的影响。

Effect of fibronectin and von Willebrand factor on the adhesion of human fixed washed platelets to collagen immobilized beads.

作者信息

Aihara M, Takami H, Sawada Y, Morimoto S, Kariya K, Kudo I, Ueno K, Kimura A, Yoshida Y

出版信息

Thromb Res. 1986 Dec 1;44(5):661-72. doi: 10.1016/0049-3848(86)90167-2.

DOI:10.1016/0049-3848(86)90167-2
PMID:3101223
Abstract

The adhesion of human fixed washed platelets (FWP) to collagen was measured using collagen immobilized beads. The addition of normal plasma or severe von Willebrand disease (VWD) plasma to FWP decreased the adhesion, suggesting the presence of some inhibitors of platelet adhesion in human plasma. Although the adhesion of FWP in severe VWD plasma was not different from that of FWP in normal plasma, the addition of purified von Willebrand factor (vWF, 1-2 mu/ml ristocetin cofactor) to FWP in buffer increased the FWP adhesion at higher flow rates, and the percent of adhesion in the absence of vWF was 10% (collagen 500 micrograms) and 30% (collagen 1,000 micrograms) of that in the presence of vWF at 10 ml/min. The enhancing effect of the vWF on FWP adhesion was also observed by pretreatment of the collagen column with vWF suggesting the important role of bound vWF to the collagen; adhesion 72% to the collagen column (1,600 micrograms) treated with vWF and 16% to the collagen column without the pretreatment at 10 ml/min. The promoting effect of vWF was also present in some commercial factor VIII preparations which had no large or intermediate multimers of vWF antigen. The adhesion of FWP was inhibited by fibronectin (FN) and the binding of ristocetin cofactor (vWF:RCo) to collagen fiber was also inhibited by FN; bound vWF:RCo to 50 micrograms/ml collagen in the absence or presence of 125 micrograms/ml FN were 60% and 8% respectively. It is suggested that vWF, even small multimer of vWF:Ag, is involved in the initial platelet-collagen interaction at high flow rates, while plasma FN acts as one of anti-adhesion factor.

摘要

使用固定化胶原珠测量人固定洗涤血小板(FWP)与胶原的黏附。向FWP中添加正常血浆或重度血管性血友病(VWD)血浆可降低黏附,提示人血浆中存在某些血小板黏附抑制剂。尽管重度VWD血浆中FWP的黏附与正常血浆中FWP的黏附无差异,但在缓冲液中向FWP添加纯化的血管性血友病因子(vWF,1 - 2μg/ml瑞斯托霉素辅因子)可在较高流速下增加FWP的黏附,在无vWF时的黏附百分比在10 ml/min时为有vWF时的10%(胶原500μg)和30%(胶原1000μg)。通过用vWF预处理胶原柱也观察到vWF对FWP黏附的增强作用,提示结合在胶原上的vWF的重要作用;在10 ml/min时,与用vWF处理的胶原柱(1600μg)的黏附率为72%,与未预处理的胶原柱的黏附率为16%。vWF的促进作用在一些不含vWF抗原大或中多聚体的商业因子VIII制剂中也存在。FWP的黏附受纤连蛋白(FN)抑制,FN也抑制瑞斯托霉素辅因子(vWF:RCo)与胶原纤维的结合;在不存在或存在125μg/ml FN时,与50μg/ml胶原结合的vWF:RCo分别为60%和8%。提示vWF,即使是vWF:Ag的小多聚体,在高流速下参与血小板 - 胶原的初始相互作用,而血浆FN作为抗黏附因子之一发挥作用。

相似文献

1
Effect of fibronectin and von Willebrand factor on the adhesion of human fixed washed platelets to collagen immobilized beads.纤连蛋白和血管性血友病因子对人固定洗涤血小板与胶原固定微珠黏附的影响。
Thromb Res. 1986 Dec 1;44(5):661-72. doi: 10.1016/0049-3848(86)90167-2.
2
Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.血浆胶原蛋白辅助因子与血管性血友病因子抗原及瑞斯托霉素辅因子相关,但与出血时间无关。
Thromb Haemost. 1988 Jun 16;59(3):485-90.
3
Platelet-collagen interactions: increase in rate of adhesion of fixed washed platelets by factor VIII-related antigen.血小板与胶原蛋白的相互作用:因子VIII相关抗原增加固定洗涤血小板的黏附速率。
Blood. 1984 Mar;63(3):495-501.
4
Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.凝血因子VIII-血管性血友病因子和纤连蛋白在流动血液中血小板与单体及纤维状I型和III型人胶原蛋白相互作用中的作用。
J Clin Invest. 1985 Feb;75(2):531-40. doi: 10.1172/JCI111729.
5
Glycoprotein Ib has a partial role in platelet-von Willebrand factor collagen interaction.糖蛋白Ib在血小板-血管性血友病因子-胶原蛋白相互作用中起部分作用。
Thromb Haemost. 1988 Oct 31;60(2):182-7.
6
Factor XIII is not involved in human platelet-collagen interaction.因子 XIII 不参与人类血小板与胶原蛋白的相互作用。
Tohoku J Exp Med. 1989 Sep;159(1):37-44. doi: 10.1620/tjem.159.37.
7
High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.高分辨率多聚体分析和PFA-100血小板功能分析仪能够在血管性血友病因子辅因子活性与血管性血友病因子抗原水平无病理比值的情况下检测出2A型血管性血友病。
Clin Lab. 2012;58(11-12):1203-9.
8
Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.胶原结合酶联免疫吸附测定法与瑞斯托霉素辅因子活性测定法检测血管性血友病因子功能活性的比较研究
Semin Thromb Hemost. 2002 Apr;28(2):149-60. doi: 10.1055/s-2002-27817.
9
Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.用多聚甲醛固定的血小板:一种用于检测血管性血友病因子和血小板聚集因子的新试剂。
J Lab Clin Med. 1975 Feb;85(2):318-28.
10
Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.两种血管性血友病因子浓缩物[Biostate和AHF(高纯度)]在血管性血友病患者中的药代动力学比较。一项随机交叉、多中心研究。
Thromb Haemost. 2007 Jun;97(6):922-30.